Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

R.J. Mairs, C.L. Wideman, W.J. Angerson, T.L. Whateley, M.S. Reza, J.R. Reeves, L.M. Robertson, A. Neshasteh-Riz

    Research output: Contribution to journalArticle

    26 Citations (Scopus)

    Abstract

    As part of an NHS Executive Trent regional initiative we considered the role and cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma. The key trials and case series show an additional patient benefit of 0.8-1.1 life years over standard chemotherapy. We estimate incremental cost per life year gained of £12 800-£17 600, which reduces further if long-term benefits are considered. High dose chemotherapy in these conditions is both life-saving and cost-effective.
    Original languageEnglish
    Pages (from-to)74-80
    Number of pages6
    JournalBritish Journal of Cancer
    Volume82
    Issue number1
    DOIs
    Publication statusPublished - Jan 2000

    Keywords

    • radioiododeoxyuridine
    • glioma
    • intracerebral therapy
    • rat
    • sustained release
    • Hodgkin's disease
    • lymphoma
    • cost-effectiveness
    • high dose chemotherapy
    • transplantation

    Fingerprint Dive into the research topics of 'Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model'. Together they form a unique fingerprint.

  • Cite this

    Mairs, R. J., Wideman, C. L., Angerson, W. J., Whateley, T. L., Reza, M. S., Reeves, J. R., ... Neshasteh-Riz, A. (2000). Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model. British Journal of Cancer, 82(1), 74-80. https://doi.org/10.1054/bjoc.1999.0879